Industry News
Virus Hitches Ride On Blood Cells To Kill Cancer
Jun 15, 2012
Scientists have discovered when a cancer-killing virus is injected in the bloodstream it hitches a ride on blood cells and evades attack from the immune system, allowing it to reach cancer tumors, and start destroying cancer cells... Read More
Virus Hitches Ride On Blood Cells To Kill Cancer
Jun 15, 2012
Scientists have discovered when a cancer-killing virus is injected in the bloodstream it hitches a ride on blood cells and evades attack from the immune system, allowing it to reach cancer tumors, and start destroying cancer cells... Read More
Single Drugs That 'Target' Tumor Cells Unlikely, In The Long Term, To Benefit Patients With Advanced Cancers
Jun 15, 2012
Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns... Read More
Pathway Determined For Origin Of Most Common Form Of Brain And Spinal Cord Tumor
Jun 15, 2012
Johns Hopkins researchers say they have discovered one of the most important cellular mechanisms driving the growth and progression of meningioma, the most common form of brain and spinal cord tumor. A report on the discovery, published in the journal Molecular Cancer Research, could lead the way to the discovery of better drugs to attack these crippling tumors, the scientists say... Read More
Patients With Lou Gehrig's Disease May Benefit From Cisplatin
Jun 15, 2012
A long-used anti-cancer drug could be a starting point to develop new treatments for the incurable nerve disease known as Lou Gehrig's disease or amyotrophic lateral sclerosis (ALS), scientists are reporting. Their research showing how the drug prevents clumping of an enzyme linked to ALS appears in the Journal of the American Chemical Society... Read More
Successful With New Immune Approach To Fighting Some Cancers
Jun 15, 2012
A national research collaboration of senior researchers, including a researcher from Moffitt Cancer Center, has found that 20 to 25 percent of "heavily pre-treated" patients with a variety of cancers who enrolled in a clinical trial had "objective and durable" responses to a treatment with BMS-936558, an antibody that specifically blocks programmed cell death 1 (PD-1)... Read More
Cancer Patient Attitudes To Clinical Trials Participation Changed By Multimedia Psychoeducational Intervention
Jun 15, 2012
Seeking ways to change cancer patients' perceptions and negative attitudes towards clinical trials participation, researchers at Moffitt Cancer Center conducted a study offering two different kinds of intervention to two groups of adults with cancer who had not previously been asked to participate in clinical trials... Read More
What Is HPV (Human Papilloma Virus)?
Jun 15, 2012
HPV, or Human Papilloma Virus, is a virus from the papillomavirus family that affects human skin and the moist membranes that line the body, such as the throat, mouth, feet, fingers, nails, anus and cervix. There are over 100 types, of which 40 can affect the genital area. Most known HPV types cause no symptoms to humans... Read More
What Is HPV (Human Papilloma Virus)?
Jun 15, 2012
HPV, or Human Papilloma Virus, is a virus from the papillomavirus family that affects human skin and the moist membranes that line the body, such as the throat, mouth, feet, fingers, nails, anus and cervix. There are over 100 types, of which 40 can affect the genital area. Most known HPV types cause no symptoms to humans... Read More
What Is HPV (Human Papilloma Virus)? What Is The HPV Vaccine
Jun 15, 2012
HPV, or Human Papilloma Virus, is a virus from the papillomavirus family that affects human skin and the moist membranes that line the body, such as the throat, mouth, feet, fingers, nails, anus and cervix. There are over 100 types, of which 40 can affect the genital area. Most known HPV types cause no symptoms to humans... Read More
Previous Page Next Page